Literature DB >> 17641022

Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse.

Giuseppe Penna1, Susana Amuchastegui, Chiara Cossetti, Francesca Aquilano, Roberto Mariani, Nadia Giarratana, Elena De Carli, Benedetta Fibbi, Luciano Adorini.   

Abstract

Chronic nonbacterial prostatitis is a poorly defined syndrome of putative autoimmune origin. To further understand its pathogenesis, we have analyzed autoimmune prostatitis in the NOD mouse, a strain genetically prone to develop different organ-specific autoimmune diseases. Spontaneous development of autoimmune prostatitis in the NOD male, defined by lymphomonuclear cell infiltration in the prostate gland, is well-established by approximately 20 wk of age and is stably maintained afterward. Disease development is indistinguishable in NOD and NOR mice, but is markedly delayed in IFN-gamma-deficient NOD mice. A T cell response to the prostate-specific autoantigen prostatic steroid-binding protein (PSBP) can be detected in NOD males before development of prostate infiltration, indicating lack of tolerance to this self Ag. The intraprostatic inflammatory infiltrate is characterized by Th1-type CD4(+) T cells, which are able to transfer autoimmune prostatitis into NOD.SCID recipients. We characterize here experimental autoimmune prostatitis, detected by intraprostatic infiltrate and PSBP-specific T cell responses, induced in 6- to 8-wk-old NOD males by immunization with synthetic peptides corresponding to the C1 subunit of PSBP. Three PSBP peptides induce in NOD mice vigorous T and B cell responses, paralleled by a marked lymphomononuclear cell infiltration in the prostate. Two of these peptides, PSBP(21-40) and PSBP(61-80), correspond to immunodominant self epitopes naturally processed in NOD mice after immunization with PSBP, whereas peptide PSBP(91-111) represents a cryptic epitope. These model systems address pathogenetic mechanisms in autoimmune prostatitis and will facilitate testing and mechanistic analysis of therapeutic approaches in this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641022     DOI: 10.4049/jimmunol.179.3.1559

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Uropathogenic Escherichia coli induces chronic pelvic pain.

Authors:  Charles N Rudick; Ruth E Berry; James R Johnson; Brian Johnston; David J Klumpp; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 2.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

3.  Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2.

Authors:  Yijie Cheng; Yanfang Cao; Awais Ullah Ihsan; Farhan Ullah Khan; Xue Li; Dianyou Xie; Xingxing Cui; Wenlu Wang; Ziwei Liu; Cunyu Li; Khalil Ali Ahmad; Kiganda Raymond Sembatya; Reyaj Mikrani; Xiaohui Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xianjin Wang; Shan Zhong; Tianyuan Xu; Leilei Xia; Xiaohua Zhang; Zhaowei Zhu; Minguang Zhang; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-11-20       Impact factor: 2.370

5.  An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.

Authors:  Jessica M Haverkamp; Bridget Charbonneau; Scott A Crist; David K Meyerholz; Michael B Cohen; Paul W Snyder; Robert U Svensson; Michael D Henry; Hsing-Hui Wang; Timothy L Ratliff
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

6.  Classification of prostate cancer using a protease activity nanosensor library.

Authors:  Jaideep S Dudani; Maria Ibrahim; Jesse Kirkpatrick; Andrew D Warren; Sangeeta N Bhatia
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

7.  An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.

Authors:  Yafei Hou; Jason DeVoss; Vinh Dao; Serena Kwek; Jeffrey P Simko; Douglas G McNeel; Mark S Anderson; Lawrence Fong
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

Review 8.  Experimental autoimmune prostatitis: different antigens induction and antigen-specific therapy.

Authors:  Yuqian Liu; Junaid Wazir; Meng Tang; Rahat Ullah; Yueting Chen; Tingting Chen; Xiaohui Zhou
Journal:  Int Urol Nephrol       Date:  2020-11-16       Impact factor: 2.370

9.  Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer.

Authors:  Yin Liu; Jun Qin Mo; Qiande Hu; Gregory Boivin; Linda Levin; Shan Lu; Dianer Yang; Zhongyun Dong; Shan Lu
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

10.  A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Elias Veizi; Kenan Izgi; Fuat Bicer; Ahmet Ozer; Kerry O Grimberg; Bakytzhan Bakhautdin; Cagri Sakalar; Cemal Tasdemir; Vincent K Tuohy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-23       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.